This study will evaluate the efficacy and safety of depemokimab (GSK3511294) in participants with Chronic rhinosinusitis with nasal polyps (CRSwNP).
- Investigator
- Jeb M Justice
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
This study will evaluate the efficacy and safety of depemokimab (GSK3511294) in participants with Chronic rhinosinusitis with nasal polyps (CRSwNP).
The primary objectives of the study are: To longitudinally characterize the long-term effectiveness of DUPIXENT庐 through assessment of patient-reported symptoms, Health-Related Quality of Life (HRQoL) related to Chronic rhinosinusitis with nasal鈥�
37 publications
2023
The Laryngoscope
鈥�2022
Journal of immunology (Baltimore, Md. : 1950)
鈥�2022
Laryngoscope investigative otolaryngology
鈥�2022
American journal of rhinology & allergy
鈥�2021
Chemical senses
鈥�